South Korea 3D Cardiac Mapping Market Depth Analysis and Industry Forecast, 2020-2027

 

3D cardiac mapping is a technique that is widely accepted for identification, characterization, and localization of an arrhythmia. Cardiac mapping is a procedure in which the information from cardiac electrograms is collected and displayed. It is used to diagnose heart rhythms particularly in case of arrhythmia. This procedure is commonly done by injecting catheter into the heart chamber percutaneously to record electrograms sequentially, which is done to correlate electrograms in cardiac anatomy. New 3D cardiac mapping systems create three-dimensional model of any chamber of heart and can track exact location of the catheter.

Request for Sample Report@ https://www.alliedmarketresearch.com/request-sample/6882

COVID-19 Impact Analysis:

Due to COVID 19 pandemic other healthcare segments have to face negligence. In addition, Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. China is the center of this lethal disease. Furthermore, this disease predominantly affects the lungs, often leading to pneumonia and acute respiratory distress syndrome, adverse effects on the heart have also been observed. Conversely it has been observed that there is prevalence of Novel coronavirus in patients suffering with conditions like arrhythmia around 16.7 percent of patients developed arrhythmia. For this condition mainly 3D cardiac mapping is used. All these factors are anticipated to impact the china 3D cardiac mapping market as well in the future.

Hospitals segment dominated the 3D cardiac mapping market in 2019, and is anticipated to maintain its dominance throughout the forecast period, owing to the fact that cardiac mapping is majorly used in hospitals and clinics to perform complex arrhythmias. Moreover, surge in incidences of cardiovascular diseases in China has led to considerable rise in hospital visits by patients since recent years. Preference among patients to visit hospitals for their checkup or disease diagnosis is anticipated to propel the market growth in the future.

Key Market Players

• Abbott Laboratories
• Acutus Medical
• MicroPort Scientific Corporation
• Medtronic Plc.